Literature DB >> 24608450

Long-term outcome of decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: a prospective observational study.

Vinod Kumar Rai, Rohit Bhatia1, Kameshwar Prasad, M V Padma Srivastava, Shaily Singh, Neha Rai, Ashish Suri.   

Abstract

BACKGROUND: Malignant middle cerebral artery (MCA) infarction is associated with high mortality and morbidity. Decompressive hemicraniectomy (DH) reduces mortality significantly but evidence for long-term functional benefit is sparse and contradictory.
MATERIALS AND METHODS: A total of 60 patients with malignant MCA infarction were prospectively enrolled. 36 (60%) patients underwent DH and 24 (40%) patients received best medical therapy alone. Both groups were followed-up for 1 year for improvement in disability and aphasia using modified Rankin score (mRS) and Western Aphasia Battery respectively. Good outcome was defined as mRS ≤ 3. Secondary analysis using mRS ≤ 4 was also performed.
RESULTS: An absolute risk reduction of 45% was observed in mortality at 1 year; 38% (14/36) in the surgical group died versus 83% (20/24) in the medical group. Good outcome at 1 year was achieved in 20% (7/35) patients in the surgical group compared with none in the medical group (P = 0.025). Repeated measures regression suggested increased proportion of patients improving over time (discharge, 3, 6 and 12 months). Surgery reduced the odds of moderate to severe disability (mRS ≥ 4) by 93.5% (odds ratio: 0.064, 95% confidence interval: 0.01-0.045, P = 0.006).
CONCLUSIONS: DH in malignant MCA infarction not only reduces mortality but also increases chances of a better functional outcome. The benefit of surgery in motor and aphasia recovery is progressive and sustained until 1 year.

Entities:  

Mesh:

Year:  2014        PMID: 24608450     DOI: 10.4103/0028-3886.128273

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

1.  Stereotactic Aspiration Acts as an Effective Treatment for Malignant Middle Cerebral Artery Infarction.

Authors:  Zhiyu Wang; Maogang Chen; Chong Wang; Jinbiao Luo; Shujie Sun; Xiangui Lu
Journal:  J Healthc Eng       Date:  2022-04-16       Impact factor: 3.822

2.  Decompressive craniectomy for the treatment of malignant infarction of the middle cerebral artery.

Authors:  XiaoCheng Lu; BaoSheng Huang; JinYu Zheng; Yi Tao; Wan Yu; LinJun Tang; RongLan Zhu; Shuai Li; LiXin Li
Journal:  Sci Rep       Date:  2014-11-17       Impact factor: 4.379

Review 3.  The Role of Decompressive Craniectomy in Limited Resource Environments.

Authors:  Angélica Clavijo; Ahsan A Khan; Juliana Mendoza; Jorge H Montenegro; Erica D Johnson; Amos O Adeleye; Andrés M Rubiano
Journal:  Front Neurol       Date:  2019-02-26       Impact factor: 4.003

4.  Decompressive Hemicraniectomy in a South American Population--Morbidity and Outcomes Analysis.

Authors:  Roberto Bezerra Vital; Pedro Tadao Hamamoto Filho; Gustavo Jose Luvizutto; Luis Gustavo Ducati; Gabriel Pereira Braga; Helio Rubens de Carvalho Nunes; Flavio Ramalho Romero; Eliana Marisa Ganem; Marco Antonio Zanini; Rodrigo Bazan
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

5.  Outcome After Decompressive Craniectomy for Middle Cerebral Artery Infarction: Timing of the Intervention.

Authors:  Taco Goedemans; Dagmar Verbaan; Bert A Coert; Bertjan Kerklaan; René van den Berg; Jonathan M Coutinho; Tessa van Middelaar; Paul J Nederkoorn; W Peter Vandertop; Pepijn van den Munckhof
Journal:  Neurosurgery       Date:  2020-03-01       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.